Success Metrics

Clinical Success Rate
100.0%

Based on 3 completed trials

Completion Rate
100%(3/3)
Active Trials
2(22%)
Results Posted
33%(1 trials)

Phase Distribution

Ph not_applicable
3
33%
Ph phase_2
2
22%
Ph phase_4
1
11%
Ph phase_3
2
22%
Ph phase_1
1
11%

Phase Distribution

1

Early Stage

2

Mid Stage

3

Late Stage

Phase Distribution9 total trials
Phase 1Safety & dosage
1(11.1%)
Phase 2Efficacy & side effects
2(22.2%)
Phase 3Large-scale testing
2(22.2%)
Phase 4Post-market surveillance
1(11.1%)
N/ANon-phased studies
3(33.3%)

Highest Phase Reached

Phase 4

Trial Status & Enrollment

Completion Rate

75.0%

3 of 4 finished

Non-Completion Rate

25.0%

1 ended early

Currently Active

2

trials recruiting

Total Trials

9

all time

Status Distribution
Active(3)
Completed(3)
Terminated(1)
Other(2)

Detailed Status

Completed3
unknown2
Recruiting2
Not yet recruiting1
Withdrawn1

Development Timeline

Analytics

Development Status

Total Trials
9
Active
2
Success Rate
100.0%
Most Advanced
Phase 4

Trials by Phase

Phase 11 (11.1%)
Phase 22 (22.2%)
Phase 32 (22.2%)
Phase 41 (11.1%)
N/A3 (33.3%)

Trials by Status

not_yet_recruiting111%
unknown222%
withdrawn111%
completed333%
recruiting222%

Recent Activity

2 active trials
Showing 5 of 9
recruitingphase_3

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

NCT05354141
not_yet_recruitingphase_4

Ketamine for Postherpetic Neuralgia With Depression

NCT06968624
recruitingnot_applicable

Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia

NCT06444737
completedphase_2

Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS

NCT04493242
withdrawnnot_applicable

Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient

NCT03777514
View all 9 trials

Clinical Trials (9)

Showing 9 of 9 trials
NCT05354141Phase 3

Extracellular Vesicle Treatment for Acute Respiratory Distress Syndrome (ARDS) (EXTINGUISH ARDS)

Recruiting
NCT06968624Phase 4

Ketamine for Postherpetic Neuralgia With Depression

Not Yet Recruiting
NCT06444737Not Applicable

Contribution of Ondansetron to Preventing Post-Dural Puncture Headaches Following Spinal Anesthesia

Recruiting
NCT04493242Phase 2

Extracellular Vesicle Infusion Treatment for COVID-19 Associated ARDS

Completed
NCT03777514Not Applicable

Intravenous (IV) Versus Oral Iron Treatment of Iron Deficiency Anemia in the Post-operative Bariatric Surgical Patient

Withdrawn
NCT02707081Phase 2

Efficacy of Intraperitoneal Versus Intravenous Lidocaine for Postcesarean Pain Relief

Completed
NCT02444260Phase 3

A Trial of Local Anaesthesia Versus Local Anaesthesia and Conscious Sedation for Hernioplasty

Unknown
NCT02037399Not Applicable

Pilot Trial on Efficacy of Single Dose Perioperative Intravenous Dexamethasone for Pain Relief After Endoscopic Submucosal Dissection

Unknown
NCT01401634Phase 1

Oral Hydration for Mild to Moderate Hyperglycemia in the Emergency Department

Completed

All 9 trials loaded

Drug Details

Intervention Type
OTHER
Total Trials
9